Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CTNM compared with BNTC: revenue, margins and what each company keeps, and the suppliers and customers both name
CTNM
Contineum Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
BNTC
Benitec Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CTNM
Contineum Therapeutics, Inc.
vs
BNTC
Benitec Biopharma Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
CTNM
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▼
−1.65%
—
BNTC
0 of 4
at or beyond implied
Report
implied
realized
× implied
Sep 15 '26
±33.9%
▼
−8.53%
×0.25
Q3 FY26
±46.8%
▲
+1.72%
×0.04
Feb 12 '26
±42.4%
▼
−2.66%
×0.06
Nov 17 '25
±33.2%
▲
+2.81%
×0.08
= implied
CTNM realized, solid
BNTC realized, hatched
One scale, both sides: full bar = 47%
× = |realized| ÷ implied
Source: market data
CTNM
Contineum Therapeutics, Inc.
Change
9.79
▲
+2.42%
Mkt cap
$359.7M
Revenue
—
BNTC
Benitec Biopharma Inc.
Change
8.64
▲
+1.71%
Regular session
Nov 3 '26
Mkt cap
$304.9M
Revenue
$7,000
Q4 FY23
vs
Compare
Regular session
Nov 3 '26
CTNM
Contineum Therapeutics, Inc.
vs
BNTC
Benitec Biopharma Inc.
9.79
▲
+2.42%
Price
8.64
▲
+1.71%
$359.7M
Mkt cap
$304.9M
—
Revenue
$7,000
Q4 FY23
Change
Change
CTNM
9.79
▲
+2.42%
vs
BNTC
8.64
▲
+1.71%
Regular session
Nov 3 '26